Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2002-4-11
pubmed:abstractText
The objectives of this study were to assess the toxicity and immunological response induced by the intradermal (i.d) administration of tumor lysate-pulsed dendritic cells (DCs).
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD14, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD40, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD86, http://linkedlifedata.com/resource/pubmed/chemical/CD83 antigen, http://linkedlifedata.com/resource/pubmed/chemical/CD86 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/HLA-DR Antigens, http://linkedlifedata.com/resource/pubmed/chemical/Hemocyanin, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulins, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/keyhole-limpet hemocyanin
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1021-32
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11948109-Adult, pubmed-meshheading:11948109-Aged, pubmed-meshheading:11948109-Antigens, CD, pubmed-meshheading:11948109-Antigens, CD14, pubmed-meshheading:11948109-Antigens, CD40, pubmed-meshheading:11948109-Antigens, CD86, pubmed-meshheading:11948109-Dendritic Cells, pubmed-meshheading:11948109-Female, pubmed-meshheading:11948109-Flow Cytometry, pubmed-meshheading:11948109-HLA-DR Antigens, pubmed-meshheading:11948109-Hemocyanin, pubmed-meshheading:11948109-Humans, pubmed-meshheading:11948109-Hypersensitivity, Delayed, pubmed-meshheading:11948109-Immunoglobulins, pubmed-meshheading:11948109-Immunophenotyping, pubmed-meshheading:11948109-Immunotherapy, Adoptive, pubmed-meshheading:11948109-Leukocytes, Mononuclear, pubmed-meshheading:11948109-Major Histocompatibility Complex, pubmed-meshheading:11948109-Male, pubmed-meshheading:11948109-Membrane Glycoproteins, pubmed-meshheading:11948109-Middle Aged, pubmed-meshheading:11948109-Neoplasm Staging, pubmed-meshheading:11948109-Neoplasms, pubmed-meshheading:11948109-Peptide Fragments, pubmed-meshheading:11948109-Treatment Outcome, pubmed-meshheading:11948109-Vaccination
pubmed:year
2002
pubmed:articleTitle
A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer.
pubmed:affiliation
Department of Surgery, University of Michigan, Ann Arbor, Michigan 48109-0932, USA. aechang@umich.edu
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't, Clinical Trial, Phase I